Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

1.3K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

460
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
460
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.2K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.5K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.5K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

653
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
653
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

571
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
571

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial Cells Promote Migration of Mesenchymal Stem Cells via PDGF-BB/PDGFR<i>β</i>-Src-Akt in the Context of Inflammatory Microenvironment upon Bone Defect.

Stem cells international·2022
Same author

KMT2B-dependent RFK transcription activates the TNF-α/NOX2 pathway and enhances ferroptosis caused by myocardial ischemia-reperfusion.

Journal of molecular and cellular cardiology·2022
Same author

Systematic analysis of prognostic and immunologic characteristics associated with coronavirus disease 2019 regulators in acute myeloid leukemia.

Frontiers in genetics·2022
Same author

Transient Oxygen Exposure Causes Profound and Lasting Changes to a Benzene-Degrading Methanogenic Community.

Environmental science & technology·2022
Same author

Alterations in sorting and secretion of hepatic apoA5 induce hypertriglyceridemia due to short-term use of olanzapine.

Frontiers in pharmacology·2022
Same author

Insights into the Seasonal Olfactory Mechanism of Geosmin in Raw Water of Huangpu River.

Toxics·2022
Same journal

Impact of altered HDL2b/HDL3 ratio on the function of innate immune cells in sepsis.

Lipids in health and disease·2026
Same journal

Interaction of hypertension and remnant cholesterol on arterial stiffness in Chinese middle-aged and elderly populations.

Lipids in health and disease·2026
Same journal

Joint effects of depression, lipid metabolic dysfunction, and their trajectories on incident cardiometabolic multimorbidity: a prospective multi-cohort analysis from two national cohorts.

Lipids in health and disease·2026
Same journal

Associations of three metabolic biomarkers with the risk of cardiometabolic multimorbidity: a national prospective study.

Lipids in health and disease·2026
Same journal

Declines in ovarian reserve associated with ambient ozone exposure: mediating role of lipid profile.

Lipids in health and disease·2026
Same journal

Association between glycolipid metabolism 7 factors (GLM7) and sarcopenia: insights from NHANES and CHARLS.

Lipids in health and disease·2026
See all related articles

Related Experiment Video

Updated: Feb 17, 2026

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

40.5K

Hypertriglyceridemia and atherosclerosis.

Jia Peng1, Fei Luo1, Guiyun Ruan1

  • 1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, 139 Middle Renmin Road, Changsha, Hunan, 410011, China.

Lipids in Health and Disease
|December 8, 2017
PubMed
Summary
This summary is machine-generated.

High triglycerides (TG) are linked to increased atherosclerotic cardiovascular disease (ASCVD) risk, but the exact mechanism is unclear. This review examines clinical studies and TG

Keywords:
AtherosclerosisAtherosclerotic cardiovascular diseaseLipoproteinTriglyceride

More Related Videos

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.8K

Related Experiment Videos

Last Updated: Feb 17, 2026

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

40.5K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.8K

Area of Science:

  • Cardiology
  • Biochemistry
  • Epidemiology

Background:

  • Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of mortality worldwide.
  • Elevated low-density lipoprotein cholesterol (LDL-C) is a well-established risk factor for atherosclerosis.
  • Emerging evidence highlights a significant association between hypertriglyceridemia and increased ASCVD risk.

Purpose of the Study:

  • To review current clinical studies investigating the link between hypertriglyceridemia and ASCVD.
  • To elucidate the proatherogenic mechanisms by which triglycerides (TG) contribute to atherosclerosis.
  • To provide a comprehensive reference for the prevention and treatment strategies of ASCVD in the context of hypertriglyceridemia.

Main Methods:

  • Systematic review of clinical research on hypertriglyceridemia and ASCVD.
  • Analysis of preclinical and clinical data on triglyceride metabolism and atherogenesis.
  • Synthesis of evidence regarding the molecular and cellular mechanisms involved in TG-induced atherosclerosis.

Main Results:

  • Hypertriglyceridemia is increasingly recognized as an independent risk factor for ASCVD.
  • Several proatherogenic mechanisms of triglycerides are being elucidated, including remnant particle formation and inflammation.
  • The precise role of TG in the development and progression of atherosclerosis requires further investigation.

Conclusions:

  • Hypertriglyceridemia represents a significant, yet often underestimated, risk factor for ASCVD.
  • Understanding the proatherogenic pathways of TG is crucial for developing targeted therapies.
  • Further research is warranted to fully clarify the mechanisms and optimize the management of hypertriglyceridemia for ASCVD prevention.